You missed the spend on ingredients to produce new product for the ramp up in H2 FY20. That is significant. I can see a cleaner balance sheet and plenty of upside for FY20. Brokers will notice this and accumulate very soon. Don't part with a share that could double in the next 6 months.
- Forums
- ASX - By Stock
- BAL
- Ann: FY19 Annual Report
Ann: FY19 Annual Report, page-166
-
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)